| Oct 1 |
High Growth Tech Stocks To Watch In October 2024
|
| Sep 27 |
J&J, Legend report Carvykti cut death risk by 45% in multiple myeloma study
|
| Sep 27 |
CARVYKTI® is the First and Only Cell Therapy to Significantly Extend Overall Survival Compared to Standard of Care in Patients with Multiple Myeloma as Early as Second Line
|
| Sep 27 |
Legend Biotech's J&J-Partnered Drug Cut The Risk Of Death By 45% In Multiple Myeloma
|
| Sep 18 |
Legend Biotech: Entering Accelerated Growth Phase, Carvykti Positions Company For Valuation Expansion
|
| Sep 14 |
Legend Biotech Corporation (LEGN): Among Hedge Funds’ Top Biotech Stock Picks
|
| Sep 12 |
Here’s Why TimesSquare Capital Management U.S. Focus Growth Strategy Removed Legend Biotech Corporation (LEGN) from its Portfolio
|
| Sep 6 |
Peering Into Legend Biotech's Recent Short Interest
|
| Sep 3 |
Matthews Emerging Markets Small Companies Fund Boosts Stake in Legend Biotech Corp
|
| Sep 2 |
Exploring 3 High Growth Tech Stocks In The United States
|
